SILMA Silmaasema OYJ

Silmäasema Oyj: Coronaria Oy Supplements the Tender Offer Document Relating to the Public Tender Offer for All Shares Issued by Silmäasema Plc

Silmäasema Oyj: Coronaria Oy Supplements the Tender Offer Document Relating to the Public Tender Offer for All Shares Issued by Silmäasema Plc

Silmäasema Oyj: Coronaria Oy Supplements the Tender Offer Document Relating to the Public Tender Offer for All Shares Issued by Silmäasema Plc



Silmäasema Oyj

Stock Exchange Release

13 November at 3:05 p.m. EET



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR HONG KONG, OR IN ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. FOR FURTHER INFORMATION, SEE SECTION “IMPORTANT INFORMATION” BELOW.



Silmäasema Oyj has today received the following information regarding Coronaria’s supplemented Tender Offer Document Relating to the Public Tender Offer for All Shares Issued by Silmäasema Plc.



Coronaria Oy (“Coronaria” or the “Offeror”) has on September 5, 2019 commenced a mandatory public tender offer to purchase all of the issued and outstanding shares in Silmäasema Oyj (“Silmäasema”) that are not held by Coronaria, Silmäasema or any of its subsidiaries (the “Tender Offer”). The subsequent offer period under the Tender Offer (the “Subsequent Offer Period”) commenced on October 2, 2019 at 9:30 a.m. (Finnish time) and expires on November 21, 2019 at 4:00 p.m. (Finnish time).

The Finnish Financial Supervisory Authority has today approved a supplement to the tender offer document relating to the Tender Offer (the “Supplement Document”). The Supplement Document relates to the unaudited interim report published by Silmäasema Oyj on November 8, 2019 for the nine months period ended September 30, 2019 (“Interim Report”), which the Offeror supplements the tender offer document with. The Supplement Document and the Interim Report are added to this release as Annex 1.

The tender offer document will be available with the Supplement Document in Finnish from November 11, 2019 onwards at the headquarters of Coronaria, Saaristonkatu 22, 3rd floor, FI-90100 Oulu, Finland, at Carnegie Investment Bank AB, Finland branch, Eteläesplanadi 22 A, 7th floor, FI-00130 Helsinki, Finland and at Nasdaq Helsinki Ltd., Fabianinkatu 14, FI-00100 Helsinki, Finland. The electronic version of the tender offer document will be available with the Supplement Document in Finnish from November 11, 2019 onwards online at /ostotarjous and /ostotarjous and in English from November 11, 2019 onwards online at /tender-offer and /tenderoffer.

Silmäasema’s operations will continue as normal and the transaction has no impact on our customers.

Annex 1: Supplement Document and Interim report



SILMÄASEMA OYJ



For further information, please contact:

CEO Jussi Salminen, tel. +358 40 834 5818

CFO Sari Nordblad, tel. +358 50 552 7247

Niina Streng, Head of Communications and Investor Relations, tel. +358 50 322 5195





Silmäasema is a Finnish company, which offers all products and services for optical retail and eye healthcare nationwide. Silmäasema is the largest private eye clinic provider offering eye surgeries and the second largest optical retail chain in Finland. The Silmäasema chain has nearly 150 stores and 13 eye clinics in Finland as well as eight stores in Estonia. The Silmäasema chain employs over 1,000 eye healthcare professionals. The Silmäasema Group’s net sales were EUR 122.9 million in 2018 and adjusted EBITDA was EUR 11.8 million.





IMPORTANT INFORMATION



THIS RELEASE MAY NOT BE RELEASED OR OTHERWISE DISTRIBUTED, IN WHOLE OR IN PART, DIRECTLY OR INDI-RECTLY, IN OR INTO, THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR HONG KONG OR IN ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW.

THIS RELEASE IS NOT A TENDER OFFER DOCUMENT AND AS SUCH DOES NOT CONSTITUTE AN OFFER OR INVI-TATION TO MAKE A SALES OFFER. IN PARTICULAR, THIS RELEASE IS NOT AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY ANY SECURITIES DESCRIBED HEREIN, AND IS NOT AN EXTENSION OF THE TENDER OFFER, IN OR INTO, THE UNITED STATES CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR HONG KONG. INVESTORS SHALL ACCEPT THE TENDER OFFER FOR THE SHARES ONLY ON THE BASIS OF THE INFORMATION PROVIDED IN A TENDER OFFER DOCUMENT. OFFERS WILL NOT BE MADE DIRECTLY OR INDIRECTLY IN ANY JURISDICTION WHERE EITHER AN OFFER OR PARTICIPATION THEREIN IS PROHIBITED BY APPLICABLE LAW OR WHERE ANY TENDER OFFER DOCUMENT OR REGISTRATION OR OTHER REQUIREMENTS WOULD APPLY IN ADDITION TO THOSE UNDERTAKEN IN FINLAND.

Attachment

EN
13/11/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Silmaasema OYJ

 PRESS RELEASE

Silmäasema Oyj: Coronaria Oy Has Gained Title to All the Shares in Si...

Silmäasema Oyj: Coronaria Oy Has Gained Title to All the Shares in Silmäasema Oyj and the Shares Have Been Delisted from Nasdaq Helsinki Coronaria Oy Has Gained Title to All the Shares in Silmäasema Oyj and the Shares Have Been Delisted from Nasdaq Helsinki Silmäasema Oyj Stock Exchange Release – Tender Offer 5 May 2020 at 4:00 p.m. EEST Coronaria Oy (“Coronaria”) has today placed security approved by the Arbitral Tribunal and thus gained title to all the shares in Silmäasema Oyj (“Silmäasema”) in accordance with Chapter 18, Section 6 of the Finnish Companies Act. After the security has...

 PRESS RELEASE

Silmäasema Oyj: Coronaria Oy on saanut omistusoikeuden Silmäasema Oy...

Silmäasema Oyj: Coronaria Oy on saanut omistusoikeuden Silmäasema Oyj:n kaikkiin osakkeisiin ja osakkeet ovat poistuneet Nasdaq Helsingin pörssilistalta Coronaria Oy on saanut omistusoikeuden Silmäasema Oyj:n kaikkiin osakkeisiin ja osakkeet ovat poistuneet Nasdaq Helsingin pörssilistalta Silmäasema Oyj                    Pörssitiedote – julkinen ostotarjous                                   5.5.2020 klo 16.00 Coronaria Oy (”Coronaria”) on tänään asettanut välimiesoikeuden hyväksymän vakuuden ja näin ollen saanut omistusoikeuden kaikkiin Silmäasema Oyj:n (”Silmäasema”) osakkeisiin osa...

 PRESS RELEASE

Silmäasema Oyj: Arbitral Tribunal Has Confirmed Coronaria Oy's Redemp...

Silmäasema Oyj: Arbitral Tribunal Has Confirmed Coronaria Oy's Redemption Right to Silmäasema Oyj's Shares and Trading in Silmäasema’s Shares Has Been Suspended Arbitral Tribunal Has Confirmed Coronaria Oy's Redemption Right to Silmäasema Oyj's Shares and Trading in Silmäasema’s Shares Has Been Suspended Silmäasema Oyj Stock Exchange Release – Tender Offer 28 April 2020 at 9:50 a.m. EEST The Arbitral Tribunal appointed by the Redemption Committee of the Finland Chamber of Commerce has on 27 April 2020 confirmed that Coronaria Oy (“Coronaria”) has the right to redeem the minority shares ...

 PRESS RELEASE

Silmäasema Oyj: Välimiesoikeus on vahvistanut Coronaria Oy:n lunastu...

Silmäasema Oyj: Välimiesoikeus on vahvistanut Coronaria Oy:n lunastusoikeuden Silmäasema Oyj:n osakkeisiin ja kaupankäynti Silmäaseman osakkeilla on keskeytetty Välimiesoikeus on vahvistanut Coronaria Oy:n lunastusoikeuden Silmäasema Oyj:n osakkeisiin ja kaupankäynti Silmäaseman osakkeilla on keskeytetty Silmäasema Oyj                    Pörssitiedote – julkinen ostotarjous                                   28.4.2020 klo 9.50 Keskuskauppakamarin lunastuslautakunnan nimittämä välimiesoikeus on 27.4.2020 vahvistanut, että Coronaria Oy:llä (”Coronaria”) on oikeus lunastaa Silmäasema Oyj:n...

 PRESS RELEASE

Silmäasema Oyj: Silmäasema Oyj Applies for Delisting of Its Shares f...

Silmäasema Oyj: Silmäasema Oyj Applies for Delisting of Its Shares from Nasdaq Helsinki Silmäasema Oyj Applies for Delisting of Its Shares from Nasdaq Helsinki Silmäasema Oyj Stock Exchange Release – Inside information 16 April 2020 at 4:05 p.m. EET Silmäasema Oyj’s (“Silmäasema”) Board of Directors has decided to apply for the termination of public trading in Silmäasema shares and the delisting of Silmäasema’s shares from the official list of Nasdaq Helsinki Ltd (“Nasdaq Helsinki”). Coronaria Oy (“Coronaria”) owns more than nine tenths (9/10) of all the shares and votes in Silmäasema a...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch